Hello. I am Jennifer.
Chat with me if you have any questions.
Esteemed Journal of the American Academy of Dermatology (JAAD) Publishes … MarketWatch (press release) In December 2009, Palomar received the first United States Food and Drug Administration (FDA) clearance for the treatment of stretch marks using a fractional non-ablative laser. In September 2010, Palomar received the first FDA clearance for a ..
Study Shows Promise for Topical Application of Living Skin Cells Following …
Angela Kariotis' One-Woman Show STRETCH MARKS at United Solo Theatre Fest 2010 Broadway World You do not have to have stretch marks to find meaning in Angela Kariotis' latest theatrical adventure – you just have to have been born. …
Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite’s lead compound, CF101, for the treatment of patients with psoriasis.
This study aims to evaluate the rate of ARF in AML patients and to delineate the impact of age, race, various co-morbid conditions and antimicrobial agents on the development of ARF.A cohort of newly diagnosed AML patients from children’s hospitals across the United States was identified using the Pediatric Health Information Systems database. Information regarding demographics, discharge diagnoses, pharmaceutical exposures, and hospital resource utilization were collected for each hospitalization for up to 1 year from AML diagnosis
Copryright 2012 - Epione Medical Corporation | About us | Treatments | Contact us | Online Store
